The Beauty Health Company (NASDAQ:SKIN) Receives Average Rating of "Hold" from Analysts

Key Points

• Analysts rate SKIN a "Hold": eight analysts average a Hold recommendation (1 sell, 6 hold, 1 buy) with an average 12‑month target of $2.32.
• Quarterly results beat estimates but company remains unprofitable: Beauty Health reported a ($0.06) EPS (beat the ($0.07) estimate) and $82.37M in revenue (vs. $78.07M est.), yet shows negative ROE (15.40%) and analysts expect ~‑$0.18 EPS for the year.
• Stock and balance-sheet snapshot: shares traded around $0.90 (52‑week range $0.76–$2.69) with a market cap of $114.8M, a high debt‑to‑equity of 3.94, and about 93.26% institutional ownership.

The Beauty Health Company (NASDAQ:SKIN - Get Free Report) has been given an average recommendation of "Hold" by the eight analysts that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $2.32.

A number of equities analysts have issued reports on SKIN shares. Jefferies Financial Group reaffirmed a "hold" rating and issued a $1.60 price objective on shares of Beauty Health in a research note on Wednesday, January 14th. TD Cowen cut their price target on Beauty Health from $1.65 to $1.50 and set a "hold" rating on the stock in a research note on Monday, March 16th. Zacks Research upgraded Beauty Health from a "strong sell" rating to a "hold" rating in a research report on Monday, March 16th. Canaccord Genuity Group decreased their price objective on Beauty Health from $1.50 to $1.00 and set a "hold" rating for the company in a research note on Friday. Finally, Benchmark reiterated a "hold" rating on shares of Beauty Health in a report on Friday, March 13th.

Beauty Health Stock Down 0.1%

Shares of SKIN opened at $0.90 on Wednesday. The business's fifty day moving average price is $0.98 and its two-hundred day moving average price is $1.25. The firm has a market capitalization of $114.83 million, a price-to-earnings ratio of -4.49 and a beta of 1.12. Beauty Health has a 52 week low of $0.76 and a 52 week high of $2.69. The company has a debt-to-equity ratio of 3.94, a quick ratio of 1.40 and a current ratio of 1.66.

Beauty Health (NASDAQ:SKIN - Get Free Report) last announced its quarterly earnings data on Thursday, March 12th. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. The firm had revenue of $82.37 million during the quarter, compared to analyst estimates of $78.07 million. Beauty Health had a negative return on equity of 15.40% and a negative net margin of 3.16%. On average, analysts predict that Beauty Health will post -0.18 earnings per share for the current year.

Institutional Trading of Beauty Health

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Public Employees Retirement System of Ohio acquired a new stake in shares of Beauty Health in the 3rd quarter valued at approximately $26,000. Franklin Resources Inc. acquired a new position in Beauty Health during the third quarter valued at approximately $31,000. Zacks Investment Management bought a new stake in Beauty Health in the third quarter valued at approximately $35,000. Ameriprise Financial Inc. bought a new stake in Beauty Health in the third quarter valued at approximately $38,000. Finally, Atom Investors LP acquired a new stake in Beauty Health in the fourth quarter worth $29,000. 93.26% of the stock is owned by institutional investors.

About Beauty Health

Beauty Health Company NASDAQ: SKIN is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health's brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.